MeSH term
Frequency | Condition_Probility | *Adaptor Proteins, Signal Transducing | 8 | 0.0 |
Animals | 11 | 0.0 |
Humans | 34 | 0.0 |
Signal Transduction/*immunology | 2 | 0.0 |
Cloning, Molecular | 5 | 0.0 |
Research Support, Non-U.S. Gov't | 11 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 10 | 0.0 |
Transfection | 3 | 0.0 |
Adult | 3 | 0.0 |
Duffy Blood-Group System/*genetics | 5 | 38.0 |
Female | 8 | 0.0 |
Gene Frequency | 6 | 0.0 |
Genotype | 6 | 0.0 |
Male | 7 | 0.0 |
Middle Aged | 2 | 0.0 |
Alleles | 3 | 0.0 |
*Antigens, Protozoan | 3 | 15.0 |
Continental Population Groups/genetics | 2 | 2.0 |
English Abstract | 2 | 0.0 |
Organ Specificity | 2 | 0.0 |
Phenotype | 9 | 0.0 |
Polymerase Chain Reaction | 4 | 0.0 |
Polymorphism, Restriction Fragment Length | 4 | 0.0 |
*Protozoan Proteins | 3 | 8.0 |
Adolescent | 2 | 0.0 |
Blood Donors | 2 | 0.0 |
Child | 2 | 0.0 |
Child, Preschool | 2 | 0.0 |
Pregnancy | 5 | 0.0 |
Amino Acid Sequence | 5 | 0.0 |
Lymphocyte Activation | 2 | 0.0 |
Molecular Sequence Data | 6 | 0.0 |
Phosphoproteins/chemistry/*metabolism | 2 | 3.0 |
Protein Binding | 3 | 0.0 |
Receptors, Antigen, T-Cell/*metabolism | 2 | 1.0 |
Duffy Blood-Group System/genetics/*immunology | 4 | 100.0 |
Isoantibodies/blood | 2 | 8.0 |
Carrier Proteins/*metabolism | 2 | 0.0 |
Interleukin-2/*biosynthesis | 2 | 1.0 |
Phosphoproteins/*metabolism | 2 | 0.0 |
Phosphorylation | 3 | 0.0 |
Protein-Tyrosine Kinase/*metabolism | 2 | 0.0 |
Proto-Oncogene Proteins/*metabolism | 2 | 0.0 |
Sequence Homology, Amino Acid | 3 | 0.0 |
Signal Transduction | 3 | 0.0 |
Up-Regulation | 2 | 0.0 |
Base Sequence | 3 | 0.0 |
Jurkat Cells | 3 | 0.0 |
Mice | 3 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
*Alleles | 2 | 0.0 |
Erythroblastosis, Fetal/immunology | 2 | 100.0 |
Homozygote | 2 | 0.0 |
Infant, Newborn | 2 | 0.0 |
*Polymerase Chain Reaction | 2 | 0.0 |
Blood Grouping and Crossmatching | 2 | 2.0 |
COS Cells | 2 | 0.0 |
*Blood Donors | 3 | 2.0 |
DNA Primers | 2 | 0.0 |
Erythrocytes/*immunology | 2 | 1.0 |
Cell Line | 2 | 0.0 |
*Blood Transfusion | 2 | 1.0 |
Blood Group Antigens/*immunology | 2 | 6.0 |
Malaria/*blood | 3 | 21.0 |
Plasmodium vivax | 2 | 50.0 |
*Blood Group Antigens | 7 | 13.0 |
Erythrocytes/immunology | 2 | 0.0 |
